Expert Ratings For Inspire Medical Systems
Portfolio Pulse from Benzinga Insights
In the latest quarter, 6 analysts provided ratings for Inspire Medical Systems (NYSE:INSP), showing a mix of bullish and bearish perspectives. The average 12-month price target has risen by 3.79% to $250.83. Key analysts have adjusted their ratings and price targets, reflecting their views on the company's performance and market conditions.
June 03, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inspire Medical Systems (NYSE:INSP) received mixed ratings from analysts, with an average price target increase of 3.79% to $250.83. Key analysts have adjusted their ratings and price targets, reflecting their views on the company's performance and market conditions.
The mixed ratings and the increase in the average price target suggest a cautiously optimistic outlook for INSP. The adjustments by key analysts indicate a positive shift in sentiment, which could lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100